相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review
Mattia Bellan et al.
AUTOIMMUNITY REVIEWS (2020)
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
Bridget F. Collins et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Reliability and Minimal Clinically Important Differences of FVC Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
Suzanne Kafaja et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review
Mathilde Thiebaut et al.
AUTOIMMUNITY REVIEWS (2018)
Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial
Geetabali Sircar et al.
RHEUMATOLOGY (2018)
Hematopoietic stem-cell transplantation in systemic sclerosis: an update
Julia Spierings et al.
CURRENT OPINION IN RHEUMATOLOGY (2018)
Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients
Alper Sari et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2017)
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease
Dimitrios Daoussis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Rituximab for the therapy of systemic sclerosis: a series of 10 cases in a single center
Veronica Silva Vilela et al.
REVISTA BRASILEIRA DE REUMATOLOGIA (2016)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
IMPACT OF ANTI-B-CELL THERAPY WITH RITUXIMAB ON PULMONARY FUNCTION OF THE PATIENTS WITH SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE
O. Koneva et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Interstitial Lung Disease in Scleroderma
Sara R. Schoenfeld et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2015)
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis
Silvia L. Bosello et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Suzana Jordan et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases Results of a lower dosage and shorter interval regimen
F. C. Moazedi-Fuerst et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2014)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Using cyclophosphamide in inflammatory rheumatic diseases
Tobias Brummaier et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2013)
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies
Muriel Elhai et al.
RHEUMATOLOGY (2012)
Good and Bad Memories Following Rituximab Therapy
E. William St Clair
ARTHRITIS AND RHEUMATISM (2010)
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
Dimitrios Daoussis et al.
RHEUMATOLOGY (2010)
B Cell Depletion With Rituximab in Patients With Diffuse Cutaneous Systemic Sclerosis
Robert Lafyatis et al.
ARTHRITIS AND RHEUMATISM (2009)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The precision of longitudinal lung function measurements: monitoring and interpretation
E Hnizdo et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2005)
Aging of the respiratory system: Impact on pulmonary function tests and adaptation to exertion
JP Janssens
CLINICS IN CHEST MEDICINE (2005)
Altered blood B lymphocyte Homeostasis in systemic sclerosis - Expanded naive B cells and diminished but activated memory B cells
S Sato et al.
ARTHRITIS AND RHEUMATISM (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
